ReP USP - Resultado da busca

Artigo de periodico
Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial (2023)
Rossi, Giordano Novak ; Rocha, Juliana Mendes; Osório, Flávia de Lima ; Bouso, José Carlos ; Ona, Genís ; Silveira, Gabriela de Oliveira; Yonamine, Maurício ; Bertozi, Giuliana; Crevelin, Eduardo José ; Queiroz, Maria Eugênia; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Source: Journal of Clinical Psychopharmacology. Unidades: FMRP, FCF, FFCLRP, ESALQ
Subjects: ALUCINOGÊNICOS, CANABINOIDES, COGNIÇÃO SOCIAL, EMOÇÕES, EXPRESSÃO FACIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial. Journal of Clinical Psychopharmacology, v. 43, n. 4, p. 339-349, 2023Tradução . . Disponível em: https://doi.org/10.1097/JCP.0000000000001691. Acesso em: 05 dez. 2023.
APA
Rossi, G. N., Rocha, J. M., Osório, F. de L., Bouso, J. C., Ona, G., Silveira, G. de O., et al. (2023). Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial. Journal of Clinical Psychopharmacology, 43( 4), 339-349. doi:10.1097/JCP.0000000000001691
NLM
Rossi GN, Rocha JM, Osório F de L, Bouso JC, Ona G, Silveira G de O, Yonamine M, Bertozi G, Crevelin EJ, Queiroz ME, Crippa JA de S, Hallak JEC, Santos RG dos. Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2023 ; 43( 4): 339-349.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1097/JCP.0000000000001691
Vancouver
Rossi GN, Rocha JM, Osório F de L, Bouso JC, Ona G, Silveira G de O, Yonamine M, Bertozi G, Crevelin EJ, Queiroz ME, Crippa JA de S, Hallak JEC, Santos RG dos. Interactive effects of Ayahuasca and Cannabidiol in social cognition in healthy volunteers: a pilot, proof-of-concept, feasibility, randomized-controlled trial [Internet]. Journal of Clinical Psychopharmacology. 2023 ; 43( 4): 339-349.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1097/JCP.0000000000001691
Artigo de periodico
Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] (2022)
Poli Netto, Omero Benedicto ; Hallak, Jaime Eduardo Cecílio; Rosa e Silva, Júlio César; Crippa, José Alexandre de Souza
Source: Revista Brasileira de Ginecologia e Obstetricia. Unidade: FMRP
Subjects: CANNABIS, ENDOMETRIOSE, FARMACOTERAPIA, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLI NETTO, Omero Benedicto et al. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial]. Revista Brasileira de Ginecologia e Obstetricia, v. 44, n. 5, p. 449-451, 2022Tradução . . Disponível em: https://doi.org/10.1055/s-0042-1749430. Acesso em: 05 dez. 2023.
APA
Poli Netto, O. B., Hallak, J. E. C., Rosa e Silva, J. C., & Crippa, J. A. de S. (2022). Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial]. Revista Brasileira de Ginecologia e Obstetricia, 44( 5), 449-451. doi:10.1055/s-0042-1749430
NLM
Poli Netto OB, Hallak JEC, Rosa e Silva JC, Crippa JA de S. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetricia. 2022 ; 44( 5): 449-451.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1055/s-0042-1749430
Vancouver
Poli Netto OB, Hallak JEC, Rosa e Silva JC, Crippa JA de S. Is it the ideal time to start prescribing Cannabis derivatives to treat endometriosis-associated pain ? [Editorial] [Internet]. Revista Brasileira de Ginecologia e Obstetricia. 2022 ; 44( 5): 449-451.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1055/s-0042-1749430
Artigo de periodico
Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) (2022)
Souza, José Diogo Ribeiro de; Pacheco, Júlia Cozar; Rossi, Giordano Novak ; Paulo, Bruno O. de; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Santos, Rafael Guimarães dos
Source: Pharmaceutics. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo Ribeiro de et al. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, v. 14, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122598. Acesso em: 05 dez. 2023.
APA
Souza, J. D. R. de, Pacheco, J. C., Rossi, G. N., Paulo, B. O. de, Zuardi, A. W., Guimarães, F. S., et al. (2022). Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, 14, 1-14. doi:10.3390/pharmaceutics14122598
NLM
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Vancouver
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Artigo de periodico
What can we learn from animal models to study schizophrenia? (2022)
Crunfli, Fernanda ; Del Bel, Elaine Aparecida ; Gomes, Felipe Villela ; Teles, Caroline Brandão; Zuccoli, Giuliana S.; Chaves Filho, Adriano J. M.; Vieira, Gabriela Maciel ; Amaral, Danyelle Silva; Crippa, José Alexandre de Souza ; Pedrazzi, João Francisco Cordeiro; Macêdo, Danielle S.
Source: Advances in Experimental Medicine and Biology. Unidades: FMRP, FORP
Subjects: ESQUIZOFRENIA, MODELOS ANIMAIS, TRANSTORNOS PSICÓTICOS, NEUROTRANSMISSORES, GLUTAMATOS, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUNFLI, Fernanda et al. What can we learn from animal models to study schizophrenia?. Advances in Experimental Medicine and Biology, v. 1400, p. 15-33, 2022Tradução . . Disponível em: https://doi.org/10.1007/978-3-030-97182-3_2. Acesso em: 05 dez. 2023.
APA
Crunfli, F., Del Bel, E. A., Gomes, F. V., Teles, C. B., Zuccoli, G. S., Chaves Filho, A. J. M., et al. (2022). What can we learn from animal models to study schizophrenia? Advances in Experimental Medicine and Biology, 1400, 15-33. doi:10.1007/978-3-030-97182-3_2
NLM
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Vancouver
Crunfli F, Del Bel EA, Gomes FV, Teles CB, Zuccoli GS, Chaves Filho AJM, Vieira GM, Amaral DS, Crippa JA de S, Pedrazzi JFC, Macêdo DS. What can we learn from animal models to study schizophrenia? [Internet]. Advances in Experimental Medicine and Biology. 2022 ; 1400 15-33.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/978-3-030-97182-3_2
Artigo de periodico
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters (2022)
Crippa, José Alexandre de Souza ; Pereira Junior, Luiz C.; Pereira, Lívia C.; Zimmermann, Patrícia M.; Brum Júnior, Liberato; Rechia, Letícia Mello; Dias, Isabella Caroline da Silva; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de; Guimarães, Francisco Silveira ; Queiroz, Regina Helena Costa; Zuardi, Antonio Waldo
Source: Brazilian Journal of Psychiatry. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, FARMACOTERAPIA, FARMACODINÂMICA, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, v. 44, n. 1, p. 15-20, 2022Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1684. Acesso em: 05 dez. 2023.
APA
Crippa, J. A. de S., Pereira Junior, L. C., Pereira, L. C., Zimmermann, P. M., Brum Júnior, L., Rechia, L. M., et al. (2022). Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Brazilian Journal of Psychiatry, 44( 1), 15-20. doi:10.1590/1516-4446-2020-1684
NLM
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Vancouver
Crippa JA de S, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Júnior L, Rechia LM, Dias IC da S, Hallak JEC, Campos AC de, Guimarães FS, Queiroz RHC, Zuardi AW. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters [Internet]. Brazilian Journal of Psychiatry. 2022 ; 44( 1): 15-20.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1590/1516-4446-2020-1684
Artigo de periodico
Case report: cannabidiol-induced skin rash: a case series and key recommendations (2022)
Souza, José Diogo dos Santos; Fassoni-Ribeiro, Maíra; Batista, Rayssa Miranda; Ushirohira, Juliana Mayumi; Zuardi, Antonio Waldo; Guimarães, Francisco Silveira ; Campos, Alline Cristina de; Osório, Flávia de Lima ; Elias, Daniel; Souza, Cacilda da Silva; Fassoni, Andréa Aparecida; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, FERIMENTOS E LESÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo dos Santos et al. Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, v. 13, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.881617. Acesso em: 05 dez. 2023.
APA
Souza, J. D. dos S., Fassoni-Ribeiro, M., Batista, R. M., Ushirohira, J. M., Zuardi, A. W., Guimarães, F. S., et al. (2022). Case report: cannabidiol-induced skin rash: a case series and key recommendations. Frontiers in Pharmacology, 13, 1-6. doi:10.3389/fphar.2022.881617
NLM
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fphar.2022.881617
Vancouver
Souza JD dos S, Fassoni-Ribeiro M, Batista RM, Ushirohira JM, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Elias D, Souza C da S, Fassoni AA, Hallak JEC, Crippa JA de S. Case report: cannabidiol-induced skin rash: a case series and key recommendations [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-6.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fphar.2022.881617
Artigo de periodico
Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion (2022)
Corrêa, Márcio da Silveira; Freitas, Betânia Souza de; Machado, Gustavo Dalto Barroso; Pires, Vivian Naziaseno; Bromberg, Elke; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Schröder, Nadja
Source: Behavioural Brain Research. Unidade: FMRP
Subjects: ESTRÓGENOS, CANABINOIDES, MEMÓRIA, OVARIECTOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRÊA, Márcio da Silveira et al. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion. Behavioural Brain Research, v. 417, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2021.113555. Acesso em: 05 dez. 2023.
APA
Corrêa, M. da S., Freitas, B. S. de, Machado, G. D. B., Pires, V. N., Bromberg, E., Hallak, J. E. C., et al. (2022). Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion. Behavioural Brain Research, 417. doi:10.1016/j.bbr.2021.113555
NLM
Corrêa M da S, Freitas BS de, Machado GDB, Pires VN, Bromberg E, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion [Internet]. Behavioural Brain Research. 2022 ; 417[citado 2023 dez. 05 ] Available from: https://doi.org/10.1016/j.bbr.2021.113555
Vancouver
Corrêa M da S, Freitas BS de, Machado GDB, Pires VN, Bromberg E, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion [Internet]. Behavioural Brain Research. 2022 ; 417[citado 2023 dez. 05 ] Available from: https://doi.org/10.1016/j.bbr.2021.113555
Artigo de periodico
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic (2022)
Souza, José Diogo dos Santos; Zuardi, Antonio Waldo; Guimarães, Francisco Silveira ; Osório, Flávia de Lima ; Loureiro, Sonia Regina ; Campos, Alline Cristina de; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos ; Silveira, Isabella Lara Machado ; Lima, Karina Pereira; Pacheco, Júlia Cozar; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Santos, Isabela Pires dos; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito Antonio Lopes da; Esposito, Danillo Lucas Alves ; Andraus, Maristela Haddad; Crippa, José Alexandre de Souza
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ANSIEDADE, DEPRESSÃO, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo dos Santos et al. Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic. Frontiers in Pharmacology, v. 13, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.856846. Acesso em: 05 dez. 2023.
APA
Souza, J. D. dos S., Zuardi, A. W., Guimarães, F. S., Osório, F. de L., Loureiro, S. R., Campos, A. C. de, et al. (2022). Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic. Frontiers in Pharmacology, 13, 1-9. doi:10.3389/fphar.2022.856846
NLM
Souza JD dos S, Zuardi AW, Guimarães FS, Osório F de L, Loureiro SR, Campos AC de, Hallak JEC, Santos RG dos, Silveira ILM, Lima KP, Pacheco JC, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Andraus MH, Crippa JA de S. Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-9.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fphar.2022.856846
Vancouver
Souza JD dos S, Zuardi AW, Guimarães FS, Osório F de L, Loureiro SR, Campos AC de, Hallak JEC, Santos RG dos, Silveira ILM, Lima KP, Pacheco JC, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Andraus MH, Crippa JA de S. Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-9.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fphar.2022.856846
Artigo de periodico
Monitoring the mental health and professional overload of health workers in Brazil: a longitudinal study considering the first wave of the COVID-19 pandemic (2022)
Osório, Flávia de Lima ; Zuardi, Antonio Waldo; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Lima, Karina Pereira; Loureiro, Sonia Regina
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: COVID-19, ANSIEDADE, SAÚDE MENTAL, ESTRESSE PROFISSIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSÓRIO, Flávia de Lima et al. Monitoring the mental health and professional overload of health workers in Brazil: a longitudinal study considering the first wave of the COVID-19 pandemic. Frontiers in Psychiatry, v. 13, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2022.852157. Acesso em: 05 dez. 2023.
APA
Osório, F. de L., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., Lima, K. P., & Loureiro, S. R. (2022). Monitoring the mental health and professional overload of health workers in Brazil: a longitudinal study considering the first wave of the COVID-19 pandemic. Frontiers in Psychiatry, 13, 1-11. doi:10.3389/fpsyt.2022.852157
NLM
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Lima KP, Loureiro SR. Monitoring the mental health and professional overload of health workers in Brazil: a longitudinal study considering the first wave of the COVID-19 pandemic [Internet]. Frontiers in Psychiatry. 2022 ; 13 1-11.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fpsyt.2022.852157
Vancouver
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Lima KP, Loureiro SR. Monitoring the mental health and professional overload of health workers in Brazil: a longitudinal study considering the first wave of the COVID-19 pandemic [Internet]. Frontiers in Psychiatry. 2022 ; 13 1-11.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fpsyt.2022.852157
Artigo de periodico
Workplace protections and Burnout among Brazilian frontline health care professionals during the COVID-19 pandemic (2022)
Pereira-Lima, Karina; Loureiro, Sonia Regina ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Osório, Flávia de Lima
Source: Frontiers in Psychology. Unidade: FMRP
Subjects: COVID-19, ESTRESSE PROFISSIONAL, SAÚDE OCUPACIONAL, SAÚDE MENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-LIMA, Karina et al. Workplace protections and Burnout among Brazilian frontline health care professionals during the COVID-19 pandemic. Frontiers in Psychology, v. 13, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.3389/fpsyg.2022.880049. Acesso em: 05 dez. 2023.
APA
Pereira-Lima, K., Loureiro, S. R., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., & Osório, F. de L. (2022). Workplace protections and Burnout among Brazilian frontline health care professionals during the COVID-19 pandemic. Frontiers in Psychology, 13, 1-6. doi:10.3389/fpsyg.2022.880049
NLM
Pereira-Lima K, Loureiro SR, Silveira ILM, Crippa JA de S, Hallak JEC, Zuardi AW, Osório F de L. Workplace protections and Burnout among Brazilian frontline health care professionals during the COVID-19 pandemic [Internet]. Frontiers in Psychology. 2022 ; 13 1-6.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fpsyg.2022.880049
Vancouver
Pereira-Lima K, Loureiro SR, Silveira ILM, Crippa JA de S, Hallak JEC, Zuardi AW, Osório F de L. Workplace protections and Burnout among Brazilian frontline health care professionals during the COVID-19 pandemic [Internet]. Frontiers in Psychology. 2022 ; 13 1-6.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3389/fpsyg.2022.880049
Artigo de periodico
Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes (2022)
Almeida, Valéria de; Seabra, Gabriela; Oliveira, Guilherme Reis de; Zuccoli, Giuliana S.; Rumin, Priscila; Fioramonte, Mariana; Smith, Bradley J.; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de ; Crippa, José Alexandre de Souza ; Souza, Daniel Martins de
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: CANABINOIDES, PROLIFERAÇÃO CELULAR, TRANSDUÇÃO DE SINAL CELULAR, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria de et al. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, v. 272, n. 7, p. 1311-1323, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01425-5. Acesso em: 05 dez. 2023.
APA
Almeida, V. de, Seabra, G., Oliveira, G. R. de, Zuccoli, G. S., Rumin, P., Fioramonte, M., et al. (2022). Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, 272( 7), 1311-1323. doi:10.1007/s00406-022-01425-5
NLM
Almeida V de, Seabra G, Oliveira GR de, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC de, Crippa JA de S, Souza DM de. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 7): 1311-1323.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/s00406-022-01425-5
Vancouver
Almeida V de, Seabra G, Oliveira GR de, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC de, Crippa JA de S, Souza DM de. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 7): 1311-1323.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/s00406-022-01425-5
Artigo de periodico
Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS (2022)
Cruz, Jonas Carneiro ; Rosa, Mariana Azevedo; Morés, Lucas; Carasek, Eduardo; Crippa, José Alexandre de Souza ; Figueiredo, Eduardo Costa; Queiroz, Maria Eugênia Costa
Source: Analytica Chimica Acta. Unidades: FMRP, FFCLRP
Subjects: NANOTUBOS DE CARBONO, INTERAÇÕES ELETROMAGNÉTICAS, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Jonas Carneiro et al. Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS. Analytica Chimica Acta, v. 1226, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.aca.2022.340160. Acesso em: 05 dez. 2023.
APA
Cruz, J. C., Rosa, M. A., Morés, L., Carasek, E., Crippa, J. A. de S., Figueiredo, E. C., & Queiroz, M. E. C. (2022). Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS. Analytica Chimica Acta, 1226. doi:10.1016/j.aca.2022.340160
NLM
Cruz JC, Rosa MA, Morés L, Carasek E, Crippa JA de S, Figueiredo EC, Queiroz MEC. Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS [Internet]. Analytica Chimica Acta. 2022 ; 1226[citado 2023 dez. 05 ] Available from: https://doi.org/10.1016/j.aca.2022.340160
Vancouver
Cruz JC, Rosa MA, Morés L, Carasek E, Crippa JA de S, Figueiredo EC, Queiroz MEC. Magnetic restricted-access carbon nanotubes for SPME to determine cannabinoids in plasma samples by UHPLC-MS/MS [Internet]. Analytica Chimica Acta. 2022 ; 1226[citado 2023 dez. 05 ] Available from: https://doi.org/10.1016/j.aca.2022.340160
Parte de monografia/livro
Tendências da pesquisa na saúde mental: 1982 - 1992 (2022)
Crippa, José Alexandre de Souza
Source: Faculdade de Medicina de Ribeirão Preto USP: quarta década. Unidade: FMRP
Subjects: UNIVERSIDADE PÚBLICA, SAÚDE MENTAL, TRANSTORNOS MENTAIS, PSIQUIATRIA, PSICOFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza. Tendências da pesquisa na saúde mental: 1982 - 1992. Faculdade de Medicina de Ribeirão Preto USP: quarta década. Tradução . Ribeirão Preto: FUNPEC Editora, 2022. . Disponível em: https://www.fmrp.usp.br/wp-content/uploads/sites/356/2022/10/USP_Quarta_Decada.pdf. Acesso em: 05 dez. 2023.
APA
Crippa, J. A. de S. (2022). Tendências da pesquisa na saúde mental: 1982 - 1992. In Faculdade de Medicina de Ribeirão Preto USP: quarta década. Ribeirão Preto: FUNPEC Editora. Recuperado de https://www.fmrp.usp.br/wp-content/uploads/sites/356/2022/10/USP_Quarta_Decada.pdf
NLM
Crippa JA de S. Tendências da pesquisa na saúde mental: 1982 - 1992 [Internet]. In: Faculdade de Medicina de Ribeirão Preto USP: quarta década. Ribeirão Preto: FUNPEC Editora; 2022. [citado 2023 dez. 05 ] Available from: https://www.fmrp.usp.br/wp-content/uploads/sites/356/2022/10/USP_Quarta_Decada.pdf
Vancouver
Crippa JA de S. Tendências da pesquisa na saúde mental: 1982 - 1992 [Internet]. In: Faculdade de Medicina de Ribeirão Preto USP: quarta década. Ribeirão Preto: FUNPEC Editora; 2022. [citado 2023 dez. 05 ] Available from: https://www.fmrp.usp.br/wp-content/uploads/sites/356/2022/10/USP_Quarta_Decada.pdf
Artigo de periodico
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials (2022)
Santos, Rafael Guimarães dos ; Rocha, Juliana Mendes; Rossi, Giordano Novak ; Osório, Flávia de Lima ; Ona, Genís ; Bouso, José Carlos ; Silveira, Gabriela de Oliveira; Yonamine, Maurício ; Marchioni, Camila ; Crevelin, Eduardo José ; Queiroz, Maria Eugênia Costa ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecílio
Source: Human Psychopharmacology. Unidades: FMRP, FCF, FFCLRP
Subjects: ALUCINOGÊNICOS, ANSIEDADE SOCIAL, TRANSTORNOS DA ANSIEDADE, CHÁ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Human Psychopharmacology, v. 37, n. 4, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.1002/hup.2834. Acesso em: 05 dez. 2023.
APA
Santos, R. G. dos, Rocha, J. M., Rossi, G. N., Osório, F. de L., Ona, G., Bouso, J. C., et al. (2022). Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials. Human Psychopharmacology, 37( 4), 1-5. doi:10.1002/hup.2834
NLM
Santos RG dos, Rocha JM, Rossi GN, Osório F de L, Ona G, Bouso JC, Silveira G de O, Yonamine M, Marchioni C, Crevelin EJ, Queiroz MEC, Crippa JA de S, Hallak JEC. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials [Internet]. Human Psychopharmacology. 2022 ; 37( 4): 1-5.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1002/hup.2834
Vancouver
Santos RG dos, Rocha JM, Rossi GN, Osório F de L, Ona G, Bouso JC, Silveira G de O, Yonamine M, Marchioni C, Crevelin EJ, Queiroz MEC, Crippa JA de S, Hallak JEC. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: results from two pilot, proof-of-concept, randomized, placebo-controlled trials [Internet]. Human Psychopharmacology. 2022 ; 37( 4): 1-5.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1002/hup.2834
Artigo de periodico
Cannabidiol treatment improves glucose metabolism and memory in sreptozotocin-induced Alzheimer’s disease rat model: a proof-of-concept study (2022)
Faria, Daniele de Paula ; Souza, Larissa Estessi de ; Duran, Fabio Luis de Souza ; Buchpiguel, Carlos Alberto ; Britto, Luiz Roberto Giorgetti de ; Crippa, José Alexandre de Souza ; Busatto Filho, Geraldo ; Gregório, Caroline Cristiano Real
Source: International Journal of Molecular Sciences. Unidades: FM, ICB, FMRP
Subjects: FISIOLOGIA, CANABINOIDES, DOENÇA DE ALZHEIMER, MODELOS ANIMAIS DE DOENÇAS, RATOS WISTAR, ANTINEOPLÁSICOS, MEMÓRIA ANIMAL, GLICOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, Daniele de Paula et al. Cannabidiol treatment improves glucose metabolism and memory in sreptozotocin-induced Alzheimer’s disease rat model: a proof-of-concept study. International Journal of Molecular Sciences, v. 23. n. 3, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23031076. Acesso em: 05 dez. 2023.
APA
Faria, D. de P., Souza, L. E. de, Duran, F. L. de S., Buchpiguel, C. A., Britto, L. R. G. de, Crippa, J. A. de S., et al. (2022). Cannabidiol treatment improves glucose metabolism and memory in sreptozotocin-induced Alzheimer’s disease rat model: a proof-of-concept study. International Journal of Molecular Sciences, 23. n. 3, 1-10. doi:10.3390/ijms23031076
NLM
Faria D de P, Souza LE de, Duran FL de S, Buchpiguel CA, Britto LRG de, Crippa JA de S, Busatto Filho G, Gregório CCR. Cannabidiol treatment improves glucose metabolism and memory in sreptozotocin-induced Alzheimer’s disease rat model: a proof-of-concept study [Internet]. International Journal of Molecular Sciences. 2022 ; 23. n. 3 1-10.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3390/ijms23031076
Vancouver
Faria D de P, Souza LE de, Duran FL de S, Buchpiguel CA, Britto LRG de, Crippa JA de S, Busatto Filho G, Gregório CCR. Cannabidiol treatment improves glucose metabolism and memory in sreptozotocin-induced Alzheimer’s disease rat model: a proof-of-concept study [Internet]. International Journal of Molecular Sciences. 2022 ; 23. n. 3 1-10.[citado 2023 dez. 05 ] Available from: https://doi.org/10.3390/ijms23031076
Artigo de periodico
Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial (2022)
Crippa, José Alexandre de Souza ; Pacheco, Júlia Cozar; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Campos, Alline Cristina de ; Osório, Flávia de Lima ; Loureiro, Sonia Regina ; Santos, Rafael Guimarães dos ; souza, José Diogo dos Santos; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Santos, Isabela Pires dos; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito Antonio Lopes da ; Esposito, Danillo Lucas Alves ; Passos, Afonso Dinis Costa ; Dal-Fabbro, Amaury Lelis ; Bellissimo-Rodrigues, Fernando ; Arruda, Eurico ; Scarpelini, Sandro ; Andraus, Maristela Haddad; Nather Junior, Júlio Cesar; Wada, Danilo Tadao; Santos, Marcel Koenigkam ; Santos, Antonio Carlos dos ; Busatto Filho, Geraldo ; Hallak, Jaime Eduardo Cecilio
Source: Cannabis And Cannabinoid Research. Unidades: FMRP, FM
Subjects: COVID-19, CANABINOIDES, ENSAIO CLÍNICO, DOENÇAS INFECCIOSAS, MEDICINA INTERNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, v. 7, n. 5, p. 658-669, 2022Tradução . . Disponível em: https://doi.org/10.1089/can.2021.0093. Acesso em: 05 dez. 2023.
APA
Crippa, J. A. de S., Pacheco, J. C., Zuardi, A. W., Guimarães, F. S., Campos, A. C. de, Osório, F. de L., et al. (2022). Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, 7( 5), 658-669. doi:10.1089/can.2021.0093
NLM
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1089/can.2021.0093
Vancouver
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1089/can.2021.0093
Artigo de periodico
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli (2022)
Abichabki, Nathália de Lima Martins ; Zacharias, Luísa Vieira; Moreira, Natália Columbaro; Bellíssimo-Rodrigues, Fernando; Moreira, Fernanda L.; Benzi, Jhohann Richard de Lima ; Ogasawara, Tânia Mara Casare; Ferreira, Joseane Cristina; Ribeiro, Camila M.; Pavan, Fernando R.; Pereira, Leonardo Régis Leira; Brancini, Guilherme Thomaz Pereira; Braga, Gilberto Ubida Leite; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Lanchote, Vera Lucia ; Cantón, Rafael; Darini, Ana Lúcia da Costa ; Andrade, Leonardo Neves de
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, REPOSICIONAMENTO DE FÁRMACOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SINERGISMO DE DROGAS, TESTES DE SENSIBILIDADE MICROBIANA, BACTÉRIAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABICHABKI, Nathália de Lima Martins et al. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, v. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-10393-8. Acesso em: 05 dez. 2023.
APA
Abichabki, N. de L. M., Zacharias, L. V., Moreira, N. C., Bellíssimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. de L., et al. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12, 1-15. doi:10.1038/s41598-022-10393-8
NLM
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Vancouver
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Artigo de periodico
Cannabidiol for the treatment of autism spectrum disorder: hope or hype? (2022)
Pedrazzi, João Francisco Cordeiro; Ferreira, Frederico Rogério; Amaral, Danyelle Silva; Lima, Daniel Antunes; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Del Bel, Elaine Aparecida ; Guimarães, Francisco Silveira ; Costa, Karla Cristinne Mancini ; Campos, Alline Cristina de; Crippa, Ana C. S.; Crippa, José Alexandre de Souza
Source: Psychopharmacology. Unidades: FMRP, FORP
Subjects: ANTIPSICÓTICOS, FARMACOTERAPIA, CANABINOIDES, CRIANÇAS EM IDADE PRÉ-ESCOLAR, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, TRANSTORNO DO ESPECTRO AUTISTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRAZZI, João Francisco Cordeiro et al. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?. Psychopharmacology, v. 239, n. 9, p. 2713-2734, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-022-06196-4. Acesso em: 05 dez. 2023.
APA
Pedrazzi, J. F. C., Ferreira, F. R., Amaral, D. S., Lima, D. A., Hallak, J. E. C., Zuardi, A. W., et al. (2022). Cannabidiol for the treatment of autism spectrum disorder: hope or hype? Psychopharmacology, 239( 9), 2713-2734. doi:10.1007/s00213-022-06196-4
NLM
Pedrazzi JFC, Ferreira FR, Amaral DS, Lima DA, Hallak JEC, Zuardi AW, Del Bel EA, Guimarães FS, Costa KCM, Campos AC de, Crippa ACS, Crippa JA de S. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? [Internet]. Psychopharmacology. 2022 ; 239( 9): 2713-2734.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/s00213-022-06196-4
Vancouver
Pedrazzi JFC, Ferreira FR, Amaral DS, Lima DA, Hallak JEC, Zuardi AW, Del Bel EA, Guimarães FS, Costa KCM, Campos AC de, Crippa ACS, Crippa JA de S. Cannabidiol for the treatment of autism spectrum disorder: hope or hype? [Internet]. Psychopharmacology. 2022 ; 239( 9): 2713-2734.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/s00213-022-06196-4
Artigo de periodico
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder (2022)
Bolsoni, Lívia Maria; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Guimarães, Francisco Silveira ; Zuardi, Antonio Waldo
Source: Psychopharmacology. Unidade: FMRP
Subjects: ANSIEDADE, FARMACOTERAPIA, CANABINOIDES, TRANSTORNOS DA ANSIEDADE, TRANSTORNO DO STRESS PÓS-TRAUMÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOLSONI, Lívia Maria et al. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, v. 239, n. 5, p. 1499-1507, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-021-06043-y. Acesso em: 05 dez. 2023.
APA
Bolsoni, L. M., Crippa, J. A. de S., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2022). Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, 239( 5), 1499-1507. doi:10.1007/s00213-021-06043-y
NLM
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/s00213-021-06043-y
Vancouver
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1007/s00213-021-06043-y
Artigo de periodico
Harmine impairs memory performance of treated rats and nontreated cagemates (2022)
Libânio, Tânia Cristina; Eufrásio, Raí A.; Niigaki, Suzy S.; Peres, Fernanda F.; Silva, Regina H.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Calzavara, Mariana B; Abílio, Vanessa C.
Source: Experimental and Clinical Psychopharmacology. Unidade: FMRP
Subjects: ALCALOIDES, APRENDIZAGEM, EMOÇÕES, TRANSTORNOS DA MEMÓRIA, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIBÂNIO, Tânia Cristina et al. Harmine impairs memory performance of treated rats and nontreated cagemates. Experimental and Clinical Psychopharmacology, v. 30, n. 6, p. 751-759, 2022Tradução . . Disponível em: https://doi.org/10.1037/pha0000525. Acesso em: 05 dez. 2023.
APA
Libânio, T. C., Eufrásio, R. A., Niigaki, S. S., Peres, F. F., Silva, R. H., Zuardi, A. W., et al. (2022). Harmine impairs memory performance of treated rats and nontreated cagemates. Experimental and Clinical Psychopharmacology, 30( 6), 751-759. doi:10.1037/pha0000525
NLM
Libânio TC, Eufrásio RA, Niigaki SS, Peres FF, Silva RH, Zuardi AW, Hallak JEC, Crippa JA de S, Calzavara MB, Abílio VC. Harmine impairs memory performance of treated rats and nontreated cagemates [Internet]. Experimental and Clinical Psychopharmacology. 2022 ; 30( 6): 751-759.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1037/pha0000525
Vancouver
Libânio TC, Eufrásio RA, Niigaki SS, Peres FF, Silva RH, Zuardi AW, Hallak JEC, Crippa JA de S, Calzavara MB, Abílio VC. Harmine impairs memory performance of treated rats and nontreated cagemates [Internet]. Experimental and Clinical Psychopharmacology. 2022 ; 30( 6): 751-759.[citado 2023 dez. 05 ] Available from: https://doi.org/10.1037/pha0000525

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration